Using intense pulsed light to treat excessive hair growth

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to evaluate the effects of intense pulsed light (IPL) treatments on individuals over 18 years old suffering from hypertrichosis and hirsutism, particularly focusing on women with polycystic ovarian syndrome (PCOS) and individuals transitioning from male to female. Participants will complete self-assessed questionnaires to provide background information, assess hair density using the Ferriman-Gallwey scale, and evaluate their quality of life through the Dermatology Life Quality Index (DLQI). The study will analyze the impact of consecutive IPL treatments on hair reduction and overall well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age and above
* Diagnosis of PCOS obtained by a gynaecologist and hirsutism,
* Diagnosis of gender dysphoria obtained after psychiatric evaluation,
* ≥3 points in hair density according to Ferriman-Gallwey scale on a specific part of the body

Exclusion Criteria:

* Language barrier causing problem in understanding questionnaires or not being able to give consent
* Hair colours of white, orange or grey hair
* Skin type 5 and above according to Fitzpatrick
* Hereditary hypertrichosis

Where it's running

• Norrlands University Hospital
  Umeå, Västerbotten County, Sweden Recruiting

Study contacts

• Study coordinator: Alexander Shayesteh, MD., PhD
• Email: alexander.shayesteh@umu.se
• Phone: +46907852078

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk factors for infraposition of implant-supported crowns in the upper front teeth

  This observational study looks at whether implant crowns in the upper front jaw end up sitting lower than neighboring teeth over time.

  Recruiting Region Västerbotten · Stockholm and 1 other locations · NCT07593131

• Palliative ERCP and RFA ablation for metastatic, inoperable pancreatic tumors

  This trial tests whether combining ERCP-guided Habib EndoHPB RFA with palliative chemotherapy can help patients with metastatic pancreatic cancer to the liver.

  Recruiting Region Västerbotten · Umeå · NCT07191418

• Male lichen sclerosus: risk factors, treatments, and effects on quality of life

  This project will follow men with lichen sclerosus to see if routine treatments (like topical corticosteroids or circumcision) influence symptoms, disease progression, and quality of life over time.

  Recruiting Region Västerbotten · Umeå · NCT06984263

• Precision medicine approach for high-risk prostate cancer

  This study is trying to understand the biology of high-risk prostate cancer by collecting samples and information from patients to find better treatment options.

  Recruiting Region Västerbotten · Umeå · NCT06687421

• Evaluating imaging techniques for high-risk prostate cancer

  This study is testing whether new imaging techniques can help doctors better understand and treat high-risk prostate cancer in patients preparing for surgery.

  Recruiting at 2 sites Phase 3 Region Västerbotten · Malmö and 1 other locations · NCT06565247

• Evaluating the role of advanced imaging in gynecological cancers

  This study is testing if advanced imaging techniques can help doctors better diagnose and treat women with cervical, endometrial, and ovarian cancers.

  Recruiting Region Västerbotten · Umeå · NCT05855941

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.